Search

Author/Creator Shien, T.

1. 134P Safety and efficacy of eribulin and trastuzumab in anti-HER2 therapy pretreated patients with HER2-positive metastatic breast cancer: A Japanese multicenter phase 2 study (SBP-04 study). (20th December 2016)

Authors:
Shien, T.; Ikeda, M.; Ohtani, S.; Hara, F.; Takahashi, M.; Tuji, H.; Yoshitomi, S.; Matsuoka, K.; Ogasawara, Y.; Taira, N.; Doihara, H.; Ohsumi, S.
Journal:
Annals of oncology
Issue:
Volume 27(2016:Sep.)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 313TiPOpen-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial). (18th September 2017)

Authors:
Shien, T.; Shimomura, A.; Uemura, Y.; Kato, H.; Kitada, M.; Kikawa, Y.; Shiba, E.; Yoshida, T.; Morimoto, T.; Toyama, T.; Aihara, T.; Mukai, H.
Journal:
Annals of oncology
Issue:
Volume 28(2017)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence. Issue 4 (April 2015)

Authors:
Okumura, Y.; Nishimura, R.; Nakatsukasa, K.; Yoshida, A.; Masuda, N.; Tanabe, M.; Shien, T.; Tanaka, S.; Arima, N.; Komoike, Y.; Taguchi, T.; Iwase, T.; Inaji, H.; Ishitobi, M.; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
Journal:
European journal of surgical oncology
Issue:
Volume 41:Issue 4(2015:Apr.)
Page Start:
548
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗